GE HealthCare Technologies (GEHC) Capital Expenditures (2022 - 2026)

GE HealthCare Technologies (GEHC) has reported Capital Expenditures for 5 consecutive years, with $100.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Capital Expenditures rose 16.28% year-over-year to $100.0 million; the trailing twelve-month figure through Jun 2026 stood at $522.0 million (up 21.4% YoY), and the FY2025 full-year result was $482.0 million, up 20.2% from the prior year.
• Capital Expenditures eased to $100.0 million in Q2 2026 per GEHC's latest filing, from $178.0 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $178.0 million in Q1 2026 and bottomed at $59.0 million in Q2 2022.
• Historically, Capital Expenditures has averaged $103.2 million across 5 years, with a median of $97.0 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Capital Expenditures soared 43.0% in 2023, then declined 8.57% in 2024.
• Over 5 years, Capital Expenditures stood at $77.0 million in 2022, then advanced by 22.08% to $94.0 million in 2023, then rose by 8.51% to $102.0 million in 2024, then surged by 31.37% to $134.0 million in 2025, then decreased by 25.37% to $100.0 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $100.0 million, $178.0 million, and $134.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.